Bone engineering by controlled delivery of osteoinductive molecules and cells

Jonathan K Leach, David J. Mooney

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Bone regeneration can be enhanced or accelerated by the delivery of osteogenic signalling factors or bone forming cells. These factors have commonly provided benefit when retained at the defect site with a delivery vehicle formed from natural or synthetic materials. Growth factors can be directly delivered as recombinant proteins or expressed by genetically modified cells to induce bone formation. Furthermore, bone regeneration has been achieved with the transplantation of various cell types that can participate in bone healing. Carriers utilised for the delivery of osteoinductive material allow for a prolonged presentation at the repair site and the timing of presentation can be readily adjusted to correspond to the extent necessary for bone regeneration. This review examines some of the recent developments in delivery systems used to manage the presentation of these factors at the desired site. Moreover, the authors provide suggestions for continued progress in bone regeneration.

Original languageEnglish (US)
Pages (from-to)1015-1027
Number of pages13
JournalExpert Opinion on Biological Therapy
Volume4
Issue number7
DOIs
StatePublished - Jul 2004
Externally publishedYes

Fingerprint

Bone Regeneration
Bone
Bone and Bones
Molecules
Cell Transplantation
Recombinant Proteins
Osteogenesis
Intercellular Signaling Peptides and Proteins
Repair
Defects

Keywords

  • Bone regeneration
  • Gene therapy
  • Growth factors
  • Osteoblasts
  • Osteoprogenitor cells

ASJC Scopus subject areas

  • Pharmacology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Genetics
  • Immunology

Cite this

Bone engineering by controlled delivery of osteoinductive molecules and cells. / Leach, Jonathan K; Mooney, David J.

In: Expert Opinion on Biological Therapy, Vol. 4, No. 7, 07.2004, p. 1015-1027.

Research output: Contribution to journalArticle

Leach, Jonathan K ; Mooney, David J. / Bone engineering by controlled delivery of osteoinductive molecules and cells. In: Expert Opinion on Biological Therapy. 2004 ; Vol. 4, No. 7. pp. 1015-1027.
@article{6db2d6143ddd487eabc875e321701e0e,
title = "Bone engineering by controlled delivery of osteoinductive molecules and cells",
abstract = "Bone regeneration can be enhanced or accelerated by the delivery of osteogenic signalling factors or bone forming cells. These factors have commonly provided benefit when retained at the defect site with a delivery vehicle formed from natural or synthetic materials. Growth factors can be directly delivered as recombinant proteins or expressed by genetically modified cells to induce bone formation. Furthermore, bone regeneration has been achieved with the transplantation of various cell types that can participate in bone healing. Carriers utilised for the delivery of osteoinductive material allow for a prolonged presentation at the repair site and the timing of presentation can be readily adjusted to correspond to the extent necessary for bone regeneration. This review examines some of the recent developments in delivery systems used to manage the presentation of these factors at the desired site. Moreover, the authors provide suggestions for continued progress in bone regeneration.",
keywords = "Bone regeneration, Gene therapy, Growth factors, Osteoblasts, Osteoprogenitor cells",
author = "Leach, {Jonathan K} and Mooney, {David J.}",
year = "2004",
month = "7",
doi = "10.1517/14712598.4.7.1015",
language = "English (US)",
volume = "4",
pages = "1015--1027",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Bone engineering by controlled delivery of osteoinductive molecules and cells

AU - Leach, Jonathan K

AU - Mooney, David J.

PY - 2004/7

Y1 - 2004/7

N2 - Bone regeneration can be enhanced or accelerated by the delivery of osteogenic signalling factors or bone forming cells. These factors have commonly provided benefit when retained at the defect site with a delivery vehicle formed from natural or synthetic materials. Growth factors can be directly delivered as recombinant proteins or expressed by genetically modified cells to induce bone formation. Furthermore, bone regeneration has been achieved with the transplantation of various cell types that can participate in bone healing. Carriers utilised for the delivery of osteoinductive material allow for a prolonged presentation at the repair site and the timing of presentation can be readily adjusted to correspond to the extent necessary for bone regeneration. This review examines some of the recent developments in delivery systems used to manage the presentation of these factors at the desired site. Moreover, the authors provide suggestions for continued progress in bone regeneration.

AB - Bone regeneration can be enhanced or accelerated by the delivery of osteogenic signalling factors or bone forming cells. These factors have commonly provided benefit when retained at the defect site with a delivery vehicle formed from natural or synthetic materials. Growth factors can be directly delivered as recombinant proteins or expressed by genetically modified cells to induce bone formation. Furthermore, bone regeneration has been achieved with the transplantation of various cell types that can participate in bone healing. Carriers utilised for the delivery of osteoinductive material allow for a prolonged presentation at the repair site and the timing of presentation can be readily adjusted to correspond to the extent necessary for bone regeneration. This review examines some of the recent developments in delivery systems used to manage the presentation of these factors at the desired site. Moreover, the authors provide suggestions for continued progress in bone regeneration.

KW - Bone regeneration

KW - Gene therapy

KW - Growth factors

KW - Osteoblasts

KW - Osteoprogenitor cells

UR - http://www.scopus.com/inward/record.url?scp=3142723994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142723994&partnerID=8YFLogxK

U2 - 10.1517/14712598.4.7.1015

DO - 10.1517/14712598.4.7.1015

M3 - Article

VL - 4

SP - 1015

EP - 1027

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

SN - 1471-2598

IS - 7

ER -